このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Astec LifeSciences 過去の業績
過去 基準チェック /06
Astec LifeSciencesの収益は年間平均-30.9%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間15.1% 0.9%割合で 増加しています。
主要情報
-30.9%
収益成長率
-30.9%
EPS成長率
| Chemicals 業界の成長 | 17.7% |
| 収益成長率 | 0.9% |
| 株主資本利益率 | -21.2% |
| ネット・マージン | -20.4% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23
Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares
Nov 17収支内訳
収支内訳
Astec LifeSciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 3,852 | -785 | 638 | 0 |
| 31 Mar 24 | 4,586 | -469 | 629 | 0 |
| 31 Dec 23 | 4,317 | -509 | 610 | 0 |
| 30 Sep 23 | 4,981 | -258 | 579 | 0 |
| 30 Jun 23 | 5,871 | 60 | 557 | 0 |
| 31 Mar 23 | 6,285 | 256 | 533 | 0 |
| 31 Dec 22 | 7,735 | 736 | 571 | 0 |
| 30 Sep 22 | 8,297 | 975 | 586 | 0 |
| 30 Jun 22 | 7,325 | 883 | 550 | 0 |
| 31 Mar 22 | 6,769 | 899 | 513 | 0 |
| 31 Dec 21 | 5,803 | 708 | 447 | 0 |
| 30 Sep 21 | 5,230 | 531 | 418 | 0 |
| 30 Jun 21 | 5,754 | 619 | 402 | 0 |
| 31 Mar 21 | 5,587 | 650 | 394 | 0 |
| 31 Dec 20 | 5,698 | 723 | 379 | 0 |
| 30 Sep 20 | 5,786 | 774 | 354 | 0 |
| 30 Jun 20 | 5,639 | 648 | 331 | 0 |
| 31 Mar 20 | 5,287 | 475 | 309 | 0 |
| 31 Dec 19 | 4,844 | 291 | 280 | 0 |
| 30 Sep 19 | 4,781 | 269 | 274 | 0 |
| 30 Jun 19 | 4,507 | 331 | 263 | 0 |
| 31 Mar 19 | 4,382 | 357 | 262 | 0 |
| 31 Dec 18 | 4,246 | 402 | 261 | 0 |
| 30 Sep 18 | 3,781 | 374 | 248 | 0 |
| 30 Jun 18 | 3,611 | 325 | 235 | 0 |
| 31 Mar 18 | 3,676 | 349 | 229 | 0 |
| 31 Dec 17 | 3,254 | 212 | 236 | 0 |
| 30 Sep 17 | 3,119 | 148 | 228 | 0 |
| 30 Jun 17 | 3,008 | 192 | 226 | 0 |
| 31 Mar 17 | 2,987 | 191 | 213 | 0 |
| 31 Dec 16 | 3,167 | -29 | 188 | 0 |
| 30 Sep 16 | 2,865 | -114 | 193 | 0 |
| 30 Jun 16 | 2,643 | -206 | 182 | 0 |
| 31 Mar 16 | 2,330 | 50 | 163 | 0 |
| 31 Dec 15 | 2,629 | -115 | 282 | 2 |
| 30 Sep 15 | 2,777 | 61 | 254 | 2 |
| 30 Jun 15 | 2,728 | 84 | 129 | 0 |
| 31 Mar 15 | 2,669 | 148 | 134 | 0 |
| 31 Dec 14 | 2,212 | 131 | 218 | 3 |
| 30 Sep 14 | 2,147 | 127 | 217 | 3 |
| 30 Jun 14 | 2,156 | 96 | 117 | 0 |
| 31 Mar 14 | 2,070 | 87 | 212 | 3 |
| 31 Dec 13 | 2,179 | 97 | 184 | 5 |
| 30 Sep 13 | 2,076 | 76 | 182 | 5 |
質の高い収益: ASTECは現在利益が出ていません。
利益率の向上: ASTECは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: ASTECは利益が出ておらず、過去 5 年間で損失は年間30.9%の割合で増加しています。
成長の加速: ASTECの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: ASTECは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( 10.7% ) と比較することは困難です。
株主資本利益率
高いROE: ASTECは現在利益が出ていないため、自己資本利益率 ( -21.22% ) はマイナスです。